Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review

Irinotecan-based regimens are used worldwide for the treatment of several recurrent or advanced gastrointestinal malignancies. In this paper we describe the cases of four patients treated in our institution who developed acute dysarthria while receiving intravenous infusion of irinotecan. In all our...

Descripción completa

Detalles Bibliográficos
Autores principales: De Lisa, Mariagrazia, Ballatore, Zelmira, Marcantognini, Giulia, Pierantoni, Chiara, Antognoli, Stefania, Pistelli, Mirco, Pagliacci, Alessandra, Berardi, Rossana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359989/
https://www.ncbi.nlm.nih.gov/pubmed/32700070
http://dx.doi.org/10.1007/s40487-019-00106-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359989/
https://www.ncbi.nlm.nih.gov/pubmed/32700070
http://dx.doi.org/10.1007/s40487-019-00106-z

Ejemplares similares